Adverse events of nusinersen: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database
Our investigation discovered potential signals of novel adverse drug events that could support clinical monitoring and risk identification of Nusinersen. However, these results should be interpreted with caution.
Authors
- Jianxiong Gui (ORCID: https://orcid.org/0000-0002-8726-2550)
- Linxue Meng
- Li Jiang (ORCID: https://orcid.org/0000-0001-8513-5446)
- Chunxue Jiang
- Lingman Wang (ORCID: https://orcid.org/0009-0005-0018-078X)
- Ran Ding (ORCID: https://orcid.org/0000-0002-7453-8968)
- Siqi Hong
- Xiaofang Zhang (ORCID: https://orcid.org/0000-0001-9866-2018)
Institutions
- Qiqihar University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1080/14740338.2024.2443796
- Citations
- 1
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.44